Wikidata

(Q62105018)

English

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

clinical trial

In more languages

Statements

title
Tandem High-Dose Therapy With Melphalan and Total Marrow Irradiation (TMI) With Peripheral Blood Progenitor Cell Support and Lenalidomide Maintenance in Multiple Myeloma: A Phase I/II Trial (English)
0 references
start time
November 2004
0 references
end time
November 2019
0 references
number of participants
86
0 references
research intervention
(RS)-cyclophosphamide
0 references
melphalan
0 references
(RS)-lenalidomide
0 references
sargramostim
0 references
lenograstim
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62105018&oldid=1857051181"